## MELI: MercadoLibre, Inc. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.99 indicates fundamental undervaluation. Quality metrics strong (ROE 41%).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($1909.84)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. MercadoLibre, Inc. (MELI): A Bull Case Theory**
- Source: Insider Monkey | 20251204T085500 | Bullish | Relevance: 100%
- This article summarizes a bullish thesis on MercadoLibre, Inc. (MELI) highlighting its dominant e-commerce and fintech ecosystem in Latin America. The company's integrated platform, including Mercado Pago, Mercado Envíos, and Mercado Crédito, creates a virtuous cycle promoting growth and strong network effects. Despite recent stock depreciation, the thesis argues that MELI's unique growth platform positions it as a long-term compounder in the region.

**2. BTIG Reiterates MercadoLibre (MELI) Buy Recommendation**
- Source: Nasdaq | 20251205T042406 | Bullish | Relevance: 100%
- BTIG has reiterated its Buy recommendation for MercadoLibre (MELI), with an average one-year price target of $2,919.16/share, suggesting a 37.71% upside. Institutional ownership in MercadoLibre has slightly decreased, though the put/call ratio indicates a bullish outlook for the stock.

**3. MercadoLibre, Inc. $MELI Shares Sold by OMERS ADMINISTRATION Corp**
- Source: MarketBeat | 20251203T042406 | Somewhat-Bullish | Relevance: 100%
- OMERS ADMINISTRATION Corp reduced its stake in MercadoLibre (NASDAQ:MELI) by 6.4%, selling 210 shares, though institutional ownership remains high at 87.62%. Despite missing EPS estimates, MercadoLibre beat revenue expectations and analysts maintain a "Moderate Buy" rating with a target price of $2,848.82. Several other institutional investors, including Norges Bank, Invesco, UBS, GQG, and Jennison, significantly increased their holdings in MELI.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | BTIG | $2750 | $2750 | 0% |
| 2025-11-24 | UBS | $2900 | $3000 | -3% |
| 2025-11-14 | BTIG | $2750 | $2750 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | BTIG | reit | Buy |
| 2025-11-24 | UBS | main | Buy |
| 2025-11-14 | BTIG | reit | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 3 ($2.31M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 38.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- JPMORGAN CHASE & CO: 7.0% (+78.3%)
- BAILLIE GIFFORD & CO: 6.5% (-5.4%)
- Morgan Stanley: 3.9% (+0.3%)
- Capital Research Glo: 3.6% (+3.4%)
- Capital World Invest: 3.4% (+1.3%)

### Key Risks

1. Long-term trend broken: trading 9.2% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.99 indicates undervaluation relative to growth. Forward P/E 34.6x attractive for 49% earnings growth. Quality metrics strong (ROE 41%). Balance sheet: $2.5B free cash flow. Revenue growth strong at 29% YoY. Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($2.3M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $101.7B |
| Beta | 1.43 |
| 52W Range | $1693.01 - $2645.22 |
| Short Interest | 1.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.99 |
| Forward P/E | 34.6 |
| Current P/E | 51.6 |
| YoY Growth | 49.2% |
| EPS Direction | FALLING |

### Technicals

MRS_20 stable at -2.0% (minimal 5-day change). Below STRENGTH zone by 6.0pp (needs >4.0% for momentum thesis). Below SMA200 (0.91x), long-term trend not supportive. MACD histogram positive (14.89), confirming momentum. RSI neutral at 46. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.96% (CS: 37) | Neutral |
| RSI_14 | 46.2 | Neutral |
| MACD Histogram | 14.89 | Bullish |
| vs SMA20 | 1.003x | Above |
| vs SMA50 | 0.959x | Below |
| vs SMA200 | 0.908x | Below |

### Decision

- **Verdict:** HOLD
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $2066.42
- **Stop Loss:** $1909.84 (7.6% risk)
- **Target:** $2379.58 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 6
- **Position Value:** $12,398.52
- **Portfolio %:** 12.40%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-24 (Est: $11.71)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $9.30 | $8.32 | -10.5% |
| 2025Q2 | $11.89 | $10.31 | -13.3% |
| 2025Q1 | $8.27 | $9.74 | +17.8% |
| 2024Q4 | $7.56 | $12.61 | +66.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*